Article

(2022) Effects of the TCF7L2 and KCNQ1 common variant on sulfonylurea response in type 2 diabetes mellitus patients: a preliminary pharmacogenetic study. Journal of Diabetes and Metabolic Disorders. pp. 133-139.

(2021) Association analysis of HHEX gene variant with type 2 diabetes risk. International Journal of Diabetes in Developing Countries. pp. 43-47. ISSN 0973-3930

(2021) Association of common genetic variants of KCNJ11 gene with the risk of type 2 diabetes mellitus. Nucleosides Nucleotides & Nucleic Acids. pp. 530-541. ISSN 1525-7770

(2020) KCNQ1 common genetic variant and type 2 diabetes mellitus risk. Journal of Diabetes and Metabolic Disorders. pp. 47-51.

(2020) MTNR1B common genetic variant is associated with type 2 diabetes mellitus risk. Gene Reports. p. 4.

(2019) Association Analysis of the HNF4A Common Genetic Variants with Type 2 Diabetes Mellitus Risk. International Journal of Molecular and Cellular Medicine. pp. 56-62. ISSN 2251-9637

(2019) The influence of a genetic variant in the KCNQ1 gene on type 2 diabetes mellitus development. Gene Reports. p. 4.

(2018) Association Analysis of the Common Genetic Variant of Pparg Gene with Type 2 Diabetes Mellitus. Diabetes Technology & Therapeutics. A113-A114. ISSN 1520-9156

(UNSPECIFIED) A pharmacogenetic pilot study of CYP2C9 common genetic variant and sulfonylureas therapeutic response in type 2 diabetes mellitus patients. Journal of Diabetes and Metabolic Disorders. p. 7.

(UNSPECIFIED) The role of the PPARG (Pro12Ala) common genetic variant on type 2 diabetes mellitus risk. Journal of Diabetes and Metabolic Disorders. p. 6.